Clinical Report: Impact of Coagulation Factor Activity on Outcomes in Acute Stroke
Overview
Expand to specify the coagulation factors studied and their implications for ischemic and hemorrhagic strokes.
Background
Stroke remains a leading cause of disability and mortality, with the coagulation system playing a crucial role in its pathophysiology. Understanding the impact of coagulation factors on stroke outcomes can inform treatment strategies and improve patient management. This study addresses the gap in knowledge regarding the prognostic value of coagulation factors in different stroke types.
Data Highlights
Factor
Association with Prognosis
p-value
FVII (HS)
Negatively associated
0.015
FIX (HS)
Negatively associated
0.049
FXII (HS)
Positively associated
0.031
Key Findings
171 out of 195 screened patients were included in the final analysis.
Hemorrhagic stroke patients were younger and had higher stroke severity than ischemic stroke patients.
In ischemic stroke, higher FXI and FXII activity correlated with unfavorable prognosis, but this was not significant after adjustment.
In hemorrhagic stroke, lower FVII and FIX activity, along with higher FXI and FXII activity, were associated with unfavorable prognosis.
FVII and FIX activity remained independently negatively associated with prognosis in hemorrhagic stroke after adjustment.
FXII activity was positively associated with unfavorable prognosis in hemorrhagic stroke patients.
Clinical Implications
Clinicians should consider the activity levels of coagulation factors when evaluating stroke patients, particularly in hemorrhagic cases. Tailoring treatment strategies based on coagulation profiles may enhance patient outcomes and guide therapeutic interventions.
Conclusion
Reiterate the importance of further research to confirm these findings in diverse patient populations.
